These findings demonstrate obesity-promoted, ATGL-mediated colonic tumorigenesis and establish the therapeutic significance of ATGL in obesity-reinforced colon cancer progression. Here, PNPLA2 is linked to obesity due to melanocortin 4 receptor deficiency.